Manhattan West Asset Management’s Medtronic MDT Stock Holding History

Manhattan West Asset Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,202	Closed	-$686K	–	143
2025 Q3	$686K	Sell	7,202 -6,251	-46%	-$575K	0.14%	94
2025 Q2	$1.17M	Sell	13,453 -224	-2%	-$19K	0.27%	71
2025 Q1	$1.23M	Sell	13,677 -13,253	-49%	-$1.19M	0.31%	69
2024 Q4	$2.15M	Buy	26,930 +2,863	+12%	+$248K	0.58%	51
2024 Q3	$2.17M	Sell	24,067 -438	-2%	-$36.8K	0.56%	55
2024 Q2	$1.93M	Sell	24,505 -3,872	-14%	-$317K	0.52%	62
2024 Q1	$2.47M	Buy	28,377 +4,219	+17%	+$360K	0.59%	55
2023 Q4	$1.99M	Buy	24,158 +10,458	+76%	+$797K	0.56%	54
2023 Q3	$992K	Buy	13,700 +2,083	+18%	+$174K	0.31%	78
2023 Q2	$1.02M	Buy	11,617 +2,300	+25%	+$198K	0.38%	73
2023 Q1	$751K	Buy	9,317 +2,653	+40%	+$216K	0.33%	78
2022 Q4	$518K	Sell	6,664 -1,670	-20%	-$135K	0.26%	80
2022 Q3	$673K	Buy	8,334 +962	+13%	+$86.5K	0.42%	68
2022 Q2	$662K	Buy	7,372 +1,383	+23%	+$140K	0.4%	68
2022 Q1	$664K	Buy	+5,989	New	+$633K	0.36%	65

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Manhattan West Asset Management's MDT Position: Q4 2025 in Review

Manhattan West Asset Management sold out of Medtronic (MDT) in Q4 2025, closing a stake of 7,202 shares — an estimated $686K sold.

Manhattan West Asset Management first reported a position in MDT in Q1 2022 and held it in 15 quarters. The position peaked at $2.47M in Q1 2024. 2,303 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

Manhattan West Asset Management reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
Manhattan West Asset Management sold 7,202 Medtronic shares in Q4 2025, an estimated $686K.
Manhattan West Asset Management first reported a position in Medtronic in Q1 2022 and held it in 15 quarters.
Manhattan West Asset Management's Medtronic position peaked at $2.47M in Q1 2024.
2,303 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Manhattan West Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.